Xin-Zu Chen

Author PubWeight™ 32.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Total vs. proximal gastrectomy for proximal gastric cancer: a systematic review and meta-analysis. Hepatogastroenterology 2012 1.24
2 Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review. PLoS One 2013 1.04
3 D2 plus para-aortic lymphadenectomy versus standardized D2 lymphadenectomy in gastric cancer surgery. Surg Today 2009 1.00
4 Effectiveness and safety of splenectomy for gastric carcinoma: a meta-analysis. World J Gastroenterol 2009 1.00
5 The Impact of Body Mass Index on the Surgical Outcomes of Patients With Gastric Cancer: A 10-Year, Single-Institution Cohort Study. Medicine (Baltimore) 2015 0.98
6 Outcomes of surgical treatment for gastric cancer patients: 11-year experience of a Chinese high-volume hospital. Med Oncol 2014 0.98
7 The effectiveness of intravenous 5-fluorouracil-containing chemotherapy after curative resection for gastric carcinoma: A systematic review of published randomized controlled trials. J Chemother 2007 0.98
8 Survival benefit and safety of no. 10 lymphadenectomy for gastric cancer patients with total gastrectomy. Medicine (Baltimore) 2014 0.98
9 Docetaxel, cisplatin and fluorouracil (DCF) regimen compared with non-taxane-containing palliative chemotherapy for gastric carcinoma: a systematic review and meta-analysis. PLoS One 2013 0.93
10 Is CD133 a biomarker for cancer stem cells of colorectal cancer and brain tumors? A meta-analysis. Int J Biol Markers 2011 0.91
11 Early nasogastric enteral nutrition for severe acute pancreatitis: a systematic review. World J Gastroenterol 2007 0.90
12 Is retrieval of >25 lymph nodes a superior criterion for locally advanced gastric cancer surgery? Ann Surg 2011 0.89
13 Neoadjuvant plus adjuvant chemotherapy benefits overall survival of locally advanced gastric cancer. World J Gastroenterol 2011 0.88
14 Immunohistochemical HER2 expression not associated with clinicopathological characteristics of stage I-III gastric cancer patients. Hepatogastroenterology 2014 0.87
15 CD133+ CD44+ subgroups may be human small intestinal stem cells. Mol Biol Rep 2010 0.86
16 Necessity of harvesting at least 25 lymph nodes in patients with stage N2-N3 resectable gastric cancer: a 10-year, single-institution cohort study. Medicine (Baltimore) 2015 0.85
17 Quality of life following laparoscopic-assisted distal gastrectomy for gastric cancer. Hepatogastroenterology 2012 0.84
18 Incidence and mortality of liver cancer in mainland China: changes in first decade of 21st century. Hepatogastroenterology 2015 0.83
19 The Value of Palliative Gastrectomy for Gastric Cancer Patients With Intraoperatively Proven Peritoneal Seeding. Medicine (Baltimore) 2015 0.83
20 Prognostic Significance of Tumor Size in 2405 Patients With Gastric Cancer: A Retrospective Cohort Study. Medicine (Baltimore) 2015 0.83
21 Clinical characteristics and prognostic factors of primary gastric lymphoma: A retrospective study with 165 cases. Medicine (Baltimore) 2016 0.82
22 Short-term versus long-term administration of single prophylactic antibiotic in elective gastric tumor surgery. Hepatogastroenterology 2012 0.81
23 Safety and survival benefit of surgical management for elderly gastric cancer patients. Hepatogastroenterology 2014 0.81
24 Transthoracic resection versus non-transthoracic resection for gastroesophageal junction cancer: a meta-analysis. PLoS One 2012 0.81
25 The mRNA and protein expression of A-kinase anchor proteins 13 in human colorectal cancer. Clin Exp Med 2009 0.81
26 Comparisons Between Different Procedures of No. 10 Lymphadenectomy for Gastric Cancer Patients With Total Gastrectomy. Medicine (Baltimore) 2015 0.81
27 Viral infections and colorectal cancer: a systematic review of epidemiological studies. Int J Cancer 2014 0.78
28 Comparison of the clinicopathological characteristics and the survival outcomes between the Siewert type II/III adenocarcinomas. Med Oncol 2014 0.78
29 Risk Factors and Survival Outcomes for Postoperative Pulmonary Complications in Gastric Cancer Patients. Hepatogastroenterology 2015 0.78
30 The feasibility and safety of early removal of nasogastric tube after total gastrectomy for gastric cancer. Hepatogastroenterology 2013 0.77
31 Pouch vs. no pouch following total gastrectomy: meta-analysis and systematic review. Am J Gastroenterol 2010 0.77
32 The Combination of D-Dimer and Peritoneal Irritation Signs as a Potential Indicator to Exclude the Diagnosis of Intestinal Necrosis. Medicine (Baltimore) 2015 0.76
33 Heparin Saline Versus Normal Saline for Flushing and Locking Peripheral Venous Catheters in Decompensated Liver Cirrhosis Patients: A Randomized Controlled Trial. Medicine (Baltimore) 2015 0.75
34 Cost-Effectiveness Analysis on Endoscopic Surveillance Among Western Patients With Barrett's Esophagus for Esophageal Adenocarcinoma Screening. Medicine (Baltimore) 2015 0.75
35 Comparison between superficial muscularis propria and deep muscularis propria infiltration in gastric cancer patients: A retrospective cohort study. Medicine (Baltimore) 2016 0.75
36 Should laparoscopic cholecystectomy be practiced in the developing world? Ann Surg 2010 0.75
37 Lessons Learned From a Case of Gastric Cancer After Liver Transplantation for Hepatocellular Carcinoma: A Case Report and Literatures Review. Medicine (Baltimore) 2016 0.75
38 Meta-analysis of laparoscopic and open distal gastrectomy for gastric carcinoma. Surg Endosc 2009 0.75
39 Learning curve for gastric cancer patients with laparoscopy-assisted distal gastrectomy: 6-year experience from a single institution in western China. Medicine (Baltimore) 2016 0.75
40 Cost-effectiveness analysis of early veno-venous hemofiltration for severe acute pancreatitis in China. World J Gastroenterol 2008 0.75
41 The role of TRAIL signal pathway in acute pancreatitis. Hepatogastroenterology 2013 0.75
42 The postoperative quality of life of two anastomosis methods of gastric tube reconstruction for proximal gastrectomy. Hepatogastroenterology 2015 0.75
43 Factors Associated With Recurrence and Survival in N0 Gastric Cancer. Ann Surg 2017 0.75
44 Comparison of hand-assisted laparoscopic gastrectomy vs. laparoscopy assisted gastrectomy for gastric cancer. Hepatogastroenterology 2015 0.75
45 Helicobacter pylori infection, atrophic gastritis, and pancreatic cancer risk: A meta-analysis of prospective epidemiologic studies. Medicine (Baltimore) 2017 0.75
46 Safety and Survival Benefit of Surgical Management for Elderly Gastric Cancer Patients. Hepatogastroenterology 2014 0.75
47 The expression of TRAIL and its receptors in gastric cancer and the apoptotic effect of rh-TRAIL on SGC7901 cells. Oncol Rep 2009 0.75